UNSPSC 85816025: Introduction of high-dose interleukin-2 into peripheral artery, open approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of high-dose interleukin-2 into peripheral artery, open approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E05002

UNSPSC 85816025, Introduction of high-dose interleukin-2 into peripheral artery, open approach, is a Commodity code that does not match the recent state and local contract opportunities sourced for this analysis. The code nominally describes a specific invasive medical procedure using immunotherapy agents; the recent opportunities instead reflect broad procurement activity across virtual urgent care, occupational health services, cancer screening, mental health and substance use treatment, EMS operations, wellness programs, and facility-based clinical staffing—none of which involve interleukin-2 administration or peripheral artery intervention.

The mismatch suggests either a classification error in how the opportunities were tagged or that the code itself sees minimal state and local procurement activity aligned with its procedural scope. The recent opportunities blocks supply no evidence of state or local governments purchasing the specific service named in UNSPSC 85816025. Given the lack of relevant recent solicitations under this code, pursuit is not supported by current market activity.